Volume | 1,277 |
|
|||||
News | - | ||||||
Day High | 27.042 | Low High |
|||||
Day Low | 26.99 |
Etf Name | Etf Symbol | Market | Stock Type |
---|---|---|---|
First Trust Nasdaq Pharmaceuticals | FTXH | NASDAQ | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
26.99 | 26.99 | 27.042 | 27.1592 | 27.17 |
Trades | Etfs Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
15 | 1,277 | 27.00 | 34,479 | - | 23.85 - 28.41 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:00:00 | 200 | 27.042 | USD |
First Trust Nasdaq Pharmaceuticals Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
0 | 0.00 | - | 710k | -156k | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News First Trust Nasdaq Pharm...
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
FTXH Historical
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 26.96 | 27.34 | 26.77 | 27.05 | 2,217 | 0.1992 | 0.74% |
1 Month | 25.75 | 27.34 | 25.73 | 26.49 | 5,525 | 1.41 | 5.47% |
3 Months | 28.16 | 28.41 | 25.73 | 27.28 | 5,220 | -1.00 | -3.55% |
6 Months | 24.46 | 28.41 | 24.3671 | 26.75 | 6,891 | 2.70 | 11.04% |
1 Year | 26.28 | 28.41 | 23.85 | 26.44 | 8,276 | 0.8792 | 3.35% |
3 Years | 26.11 | 28.59 | 23.67 | 26.41 | 11,324 | 1.05 | 4.02% |
5 Years | 20.52 | 28.59 | 16.28 | 25.65 | 9,565 | 6.64 | 32.35% |
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified. |